AAAAAA

   
Results: 1-7 |
Results: 7
HOSPITAL EPIDEMIOLOGY OF VIRAL-HEPATITIS
Authors: BOUALI MR KHEDIRI MF BENABDALLAH H HILA A BENMOUSSA M AMOR A TOUNSI C SAID N
Citation: Mr. Bouali et al., HOSPITAL EPIDEMIOLOGY OF VIRAL-HEPATITIS, Hepatology, 28(4), 1998, pp. 1712-1712
HEMODIALYSIS - A RISK FACTOR FOR HEPATITIS-E
Authors: BOUALI MR KHEDIRI MF BENABDALLAH H HMIDA J AMOR A TOUNSI C SAID N
Citation: Mr. Bouali et al., HEMODIALYSIS - A RISK FACTOR FOR HEPATITIS-E, Hepatology, 28(4), 1998, pp. 2272-2272
GENOTYPES OF HEPATITIS-C VIRUS - A NEW SUBTYPE-4
Authors: BOUALI MR KHEDIRI MF HMIDA J HILA A DAVIDSON F SIMMONDS P
Citation: Mr. Bouali et al., GENOTYPES OF HEPATITIS-C VIRUS - A NEW SUBTYPE-4, Hepatology, 26(4), 1997, pp. 332-332
PREVALENCE OF HEPATIC-LESIONS IN ASYMPTOMATIC YOUNG BLOOD-DONORS ANTI-HCV POSITIVE
Authors: BOUALI MR KHEDIRI MF ELLOUMI H HILA A BENREJEB A SAID N TOUNSI C
Citation: Mr. Bouali et al., PREVALENCE OF HEPATIC-LESIONS IN ASYMPTOMATIC YOUNG BLOOD-DONORS ANTI-HCV POSITIVE, Hepatology, 26(4), 1997, pp. 1425-1425
SEROPREVALENCE OF HEV ANTIBODIES IN TUNISIA
Authors: BOUALI MR KHEDIRI MF BENABDALLAH H HILA A BENMOUSSA M AMOR A
Citation: Mr. Bouali et al., SEROPREVALENCE OF HEV ANTIBODIES IN TUNISIA, Hepatology, 26(4), 1997, pp. 1426-1426
3 DAYS VS 7 DAYS ANTIBIOTICS IN TRIPLE THERAPY WITH OMEPRAZOLE FOR HELICOBACTER-PYLORI ERADICATION
Authors: BOUALI MR KHEDIRI MF REJEB AB HILA A ABDALLAH HB GADDES L
Citation: Mr. Bouali et al., 3 DAYS VS 7 DAYS ANTIBIOTICS IN TRIPLE THERAPY WITH OMEPRAZOLE FOR HELICOBACTER-PYLORI ERADICATION, Gut, 41, 1997, pp. 205-205
LOW REINFECTION RATE OF HELICOBACTER-PYLORI INFECTION IN DUODENAL-ULCER PATIENTS
Authors: BOUALI MR KHEDIRI MF BENREJEB A ABDELLI MN HILA A BENMOUSSA M AMOR A
Citation: Mr. Bouali et al., LOW REINFECTION RATE OF HELICOBACTER-PYLORI INFECTION IN DUODENAL-ULCER PATIENTS, Gastroenterology, 112(4), 1997, pp. 78-78
Risultati: 1-7 |